Pursuant to Regulation 24A of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMDI/ 27/2019 dated February 8 2019 and Circular No: NSE/CML/ 2023/30 dated April 10, 2023, Pharmaids Pharmaceutical has informed that it enclosed the Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024, issued by Kashinath Sahu & Co, Practicing Company Secretary.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1924.65 |
| Dr. Reddys Labs. | 1230.05 |
| Cipla | 1427.45 |
| Zydus Lifesciences | 1132.80 |
| Lupin | 2498.70 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: